AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 178 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,425,848,000 | +27.6% | 151,686 | +3.8% | 0.00% | 0.0% |
| Q2 2020 | $1,117,504,000 | +5.9% | 146,079 | -14.4% | 0.00% | 0.0% |
| Q1 2020 | $1,055,179,000 | -42.7% | 170,741 | +12.9% | 0.00% | -33.3% |
| Q4 2019 | $1,840,493,000 | +5.7% | 151,232 | +0.3% | 0.00% | 0.0% |
| Q3 2019 | $1,741,844,000 | +19.4% | 150,809 | +3.2% | 0.00% | 0.0% |
| Q2 2019 | $1,459,199,000 | -26.4% | 146,066 | -5.1% | 0.00% | -25.0% |
| Q1 2019 | $1,981,588,000 | -18.4% | 153,850 | +27.9% | 0.00% | -33.3% |
| Q4 2018 | $2,428,927,000 | -24.2% | 120,303 | +25.5% | 0.01% | +20.0% |
| Q3 2018 | $3,203,660,000 | +86.3% | 95,833 | +8.7% | 0.01% | +66.7% |
| Q2 2018 | $1,719,510,000 | +5.0% | 88,180 | +8.5% | 0.00% | 0.0% |
| Q1 2018 | $1,638,135,000 | +47.8% | 81,297 | -2.8% | 0.00% | +50.0% |
| Q4 2017 | $1,108,111,000 | -26.1% | 83,631 | +3.0% | 0.00% | -50.0% |
| Q3 2017 | $1,498,712,000 | +8.5% | 81,231 | +8.2% | 0.00% | 0.0% |
| Q2 2017 | $1,381,546,000 | -11.1% | 75,084 | +8.9% | 0.00% | 0.0% |
| Q1 2017 | $1,554,259,000 | -50.8% | 68,925 | -24.1% | 0.00% | -73.3% |
| Q4 2016 | $3,159,805,000 | +119.7% | 90,799 | +54.7% | 0.02% | +150.0% |
| Q3 2016 | $1,438,394,000 | -43.8% | 58,686 | -45.1% | 0.01% | -50.0% |
| Q2 2016 | $2,558,388,000 | +49.5% | 106,956 | +46.3% | 0.01% | +71.4% |
| Q1 2016 | $1,711,219,000 | -54.8% | 73,129 | -41.7% | 0.01% | -22.2% |
| Q4 2015 | $3,786,792,000 | +62.1% | 125,432 | +113.3% | 0.01% | +50.0% |
| Q3 2015 | $2,336,641,000 | +91.8% | 58,813 | +233.3% | 0.01% | +100.0% |
| Q2 2015 | $1,218,495,000 | +45.3% | 17,644 | +15.0% | 0.00% | +50.0% |
| Q1 2015 | $838,812,000 | -11.6% | 15,346 | -31.1% | 0.00% | -33.3% |
| Q4 2014 | $949,233,000 | -0.8% | 22,272 | -25.7% | 0.00% | +200.0% |
| Q3 2014 | $956,917,000 | +48.3% | 29,988 | -3.7% | 0.00% | 0.0% |
| Q2 2014 | $645,200,000 | +19.8% | 31,139 | +5.5% | 0.00% | – |
| Q1 2014 | $538,780,000 | +7857.2% | 29,506 | +10475.6% | 0.00% | – |
| Q4 2013 | $6,771,000 | – | 279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |